Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-13 | 2,998,908 | $0.06 | $179.93kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-12 | 1,614,541 | $0.07 | $113.02kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-11 | 1,343,801 | $0.08 | $107.50kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-10 | 1,570,947 | $0.09 | $141.39kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-09 | 850,543 | $0.11 | $93.56kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-06 | 1,236,874 | $0.12 | $148.42kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-10-10 | 3,250,000 | $0.10 | $325.00kSell |
Stuart M. Sloan | 10% Owner | 2024-09-25 | 532,486 | $0.10 | $55.38kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Stuart M. Sloan | 5,594.46% | 21,600,442 | $175.18M | Insider |
Brian G. Atwood | 5,205.62% | 20,099,097 | $163.00M | Insider |
Yk Bioventures Opportunities GP I LLC | 3,368.31% | 13,005,169 | $105.47M | Insider |
Christopher B. Ehrlich | 1,759.99% | 6,795,408 | $55.11M | Insider |
Shami Patel | 290.14% | 1,120,254 | $9.09M | Insider |
Phoenix Biotech Sponsor LLC | 259.00% | 1,000,000 | $8.11M | Insider |
Kathleen Laporte | 251.70% | 971,825 | $7.88M | Insider |
Daniel Corey | 69.39% | 267,912 | $2.17M | Insider |
Parallel Advisors LLC | 56.98% | 220,000 | $1.78M | Institution |
Robyn Rapaport | 12.95% | 50,000 | $405.50k | Insider |